139 related articles for article (PubMed ID: 1151768)
1. Antiarrhythmic and antifibrillatory properties of aprindine.
Kroll DA; Lucchesi BR
J Pharmacol Exp Ther; 1975 Aug; 194(2):427-34. PubMed ID: 1151768
[TBL] [Abstract][Full Text] [Related]
2. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
[TBL] [Abstract][Full Text] [Related]
3. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
Hashimoto K; Komori S; Ishii M; Kamiya J
J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593
[TBL] [Abstract][Full Text] [Related]
4. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts.
Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y
Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422
[TBL] [Abstract][Full Text] [Related]
5. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Gülker H; Thale J; Brisse B; Bender F
Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
[TBL] [Abstract][Full Text] [Related]
7. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
[TBL] [Abstract][Full Text] [Related]
8. Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog.
Nattel S; Pedersen DH; Zipes DP
Cardiovasc Res; 1981 Feb; 15(2):80-5. PubMed ID: 7260980
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
Ueda M; Kimoto S; Matsuda S; Kawakami M; Mroishige E; Matsumura S; Takeda H
Jpn J Pharmacol; 1975 Oct; 25(5):549-61. PubMed ID: 1221137
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
Singh J; Bala S; Kaur AH; Garg KN
Indian J Physiol Pharmacol; 1980; 24(4):329-34. PubMed ID: 7216388
[TBL] [Abstract][Full Text] [Related]
11. Studies with aprindine.
Zipes DP; Elharrar V; Gilmour RF; Heger JJ; Prystowsky EN
Am Heart J; 1980 Dec; 100(6 Pt 2):1055-62. PubMed ID: 6255785
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
Alexanian AR; Arutyunian NS; Galoyan AA
Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783
[TBL] [Abstract][Full Text] [Related]
13. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
14. Aprindine for treatment of ventricular arrhythmias in the dog.
Muir WW; Bonagura JD
Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
16. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
Almotrefi AA; Baker JB
J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
[TBL] [Abstract][Full Text] [Related]
17. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics.
Holland DR; Lacefield WB; Gonzales CR; Johnston SR; Turk JA
J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626
[TBL] [Abstract][Full Text] [Related]
18. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.
Elharrar V; Gaum WE; Zipes DP
Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439
[TBL] [Abstract][Full Text] [Related]
19. 'Early' ischemia and reperfusion-induced arrhythmias: antiarrhythmic effects of diltiazem in the conscious rat.
Kinoshita K; Hearse DJ; Braimbridge MV; Manning AS
Can J Cardiol; 1988; 4(1):37-43. PubMed ID: 3359353
[TBL] [Abstract][Full Text] [Related]
20. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
